|
[1]
|
Desai, A.D., Lavelle, M., Boursiquot, B.C., et al. (2022) Long-Term Complications of COVID-19. American Journal of Physiology-Cell Physiology, 322, C1-C11. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Rahman, S., Montero, M.T.V., Rowe, K., et al. (2021) Epidemiology, Pathogenesis, Clinical Presentations, Diagnosis and Treatment of COVID-19: A Review of Current Evidence. Expert Review of Clinical Pharmacology, 14, 601-621. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Mallhi, T.H., Safdar, A., Butt, M.H., Salman, M., Nosheen, S., Mustafa, Z.U., Khan, F.U. AND; Khan, Y.H. (2024) Atypical Complications during the Course of COVID-19: A Comprehensive Review. Medicina, 60, Article 164. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Jin, S., Lu, X. and Xu, C. (2022) COVID-19 Induces Gastrointestinal Symptoms and Affects Patients’ Prognosis. Journal of International Medical Research, 50. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Umesh, A., Pranay, K., Pandey, R.C., et al. (2022) Evidence Mapping and Review of Long-COVID and Its Underlying Pathophysiological Mechanism. Infection, 50, 1053-1066. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Del Nogal Avila, M., Das, R., Kharlyngdoh, J., et al. (2023) Cytokine Storm-Based Mechanisms for Extrapulmonary Manifestations of SARS-CoV-2 Infection. JCI Insight, 8, e166012. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ayub Baig, M.M., Adnan, M., Baig, M.U. and Ramzan, Z. (2023) Late-Onset Pulmonary Complications among Survivors of Coronavirus Disease 2019. Pakistan Journal of Medical Sciences, 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Williams, S. (2023) Emerging Research on Postacute COVID-19 Complications. JAAPA, 36, 11-15. [Google Scholar] [CrossRef]
|
|
[9]
|
Cho, J., Lee, J., Sia, C.H., et al. (2023) Extrapulmonary Manifestations and Complications of Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Systematic Review. Singapore Medical Journal, 64, 349-365. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
陈晓枫, 黄新曲, 郭希彤, 等. 新型冠状病毒肺部感染与COVID-19肺炎的CT影像学对比研究[J]. 中国CT和MRI杂志, 2023, 21(10): 64-66.
|
|
[11]
|
张晶, 王祖保, 王思静, 等. 新型冠状病毒肺炎并发症及合并症的研究进展[J]. 医学理论与实践, 2023, 36(8): 1288-1290.
|
|
[12]
|
Karki, R. and Kanneganti, T.D. (2022) Innate Immunity, Cytokine Storm, and Inflammatory Cell Death in COVID-19. Journal of Translational Medicine, 20, Article No. 542. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kalinina, O., Golovkin, A., Zaikova, E., et al. (2022) Cytokine Storm Signature in Patients with Moderate and Severe COVID-19. International Journal of Molecular Sciences, 23, Article 8879. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Oka, Y., Kodera, T., Takeshita, M., et al. (2022) Decrease of Infectious Complications in Outpatients with Autoimmune Diseases from 2019 to 2020 under the COVID-19 Pandemic: A Single-Centre, Retrospective Cohort Study in Japan. Modern Rheumatology, 32, 444-451. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
于泽玥, 孙建辉, 郝莉雨, 等. 2022年国内外免疫学进展对中医药治疗 COVID-19的启示[J]. 中国实验方剂学杂志, 2024, 1-14.
|
|
[16]
|
董陈颍, 杨鸿. 新型冠状病毒引起的细胞因子风暴及中医药治疗[J]. 中华中医药学刊, 2020, 38(7): 15-18.
|
|
[17]
|
滕石山, 瞿小旺. 新型冠状病毒中和抗体应答研究进展[J]. 中国科学(生命科学), 2023, 53(10): 1490-1498.
|
|
[18]
|
夏坤杰, 陈宇, 沈朝斌. 新型冠状病毒肺炎与固有免疫[J]. 中华传染病杂志, 2022, 40(9): 553-556.
|
|
[19]
|
郑燕, 宣守松, 刘曼曼, 等. 中医治疗新型冠状病毒肺炎合并心力衰竭1例的体会[J]. 中国中医药现代远程教育, 2024, 22(6): 64-66.
|
|
[20]
|
孙怿泽, 王哲义, 侯季秋, 等. 从“逆传心包”角度认识新型冠状病毒肺炎相关心脏并发症[J]. 世界中医药, 2020, 15(4): 529-532.
|
|
[21]
|
李贝金, 李潇, 薛嘉睿, 等. 新冠肺炎炎症风暴的机制探讨及中医药的干预作用[J]. 中国实验方剂学杂志, 2020, 26(13): 32-38.
|